News about genomics analysis tools including next generation sequencing, electrophoresis, PCR, and others
Hamburg, June 2, 2020 The Supervisory Board of Eppendorf AG has appointed Axel Jaeger as the company’s new Chief Financial Officer (CFO). The 53-year-old financial expert will take over the management of the Hamburg-based life science company’s Finance, IT and Controlling division on June 1, 2020. He succeeds Detmar Ammermann, who left the company last... Read more
ANN ARBOR, Mich. – May 28, 2020 — Swift Biosciences, Inc., a leader in commercialization of DNA and RNA library preparation kits for Next-Generation Sequencing (NGS), has announced the release of its Swift Normalase™ Amplicon Panel (SNAP) SARS-CoV-2 kit. Targeting the full viral genome in a single tube reaction with a rapid 2-hour workflow, Swift’s... Read more
Caption: CytoSMART Lux2 Duo Kit offers side-by-side comparisons between cell cultures. To download this image, click here. 26 May 2020, Eindhoven, The Netherlands – Life Science Newswire – CytoSMART Technologies today announced the launch of a new live-cell imaging system. The CytoSMART Lux2 Duo Kit offers a straightforward, cost-effective solution for researchers carrying out immediate side-by-side comparisons between cell cultures.... Read more
Tue 26th May 2020 26th May 2020, Oxford, UK: Oxford Nanopore Technologies has raised £48.4M ($59.2M) in new capital. The funding comes from new investors and existing shareholders in EMEA, US and Asia, and adds to the £29M of new capital raised in Q4 2019. Further information on Oxford Nanopore’s fundraising will be made... Read more
MAY 26, 2020 The CE-IVD marked system will enable diagnostic pathologists with new applications MINNEAPOLIS, May 26, 2020 /PRNewswire/ — Bio-Techne (NASDAQ:TECH), a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities and Leica Biosystems, a global leader in workflow solutions and automation, are proud to announce... Read more
Fri 22nd May 2020 LamPORE is designed for use in both high-throughput labs or decentralised locations- Oxford Nanopore Technologies is in advanced development of a new generation of end-to-end test (assay) for the detection of SARS-CoV-2, the virus that causes COVID-19. The LamPORE assay is designed to be rapid, low cost, and scalable to cater... Read more
Genomics insights generated through sequencing an individual’s DNA play a critical role in personalised healthcare and clinical diagnostics of the future Roche is committed to developing a nanopore sequencer with the aim of providing the healthcare community and ultimately patients with faster and more accurate medical information to predict risk and detect disease This investment... Read more
Thu 21st May 2020 Latest kit release provides 96 native barcodes for PCR-free sequencing, allowing higher numbers of samples to be run on a single flow cell – including for SARS-CoV-2 whole genome sequencing protocol. The Native Barcoding Expansion (96) kit is available to purchase on the Store now here. Oxford Nanopore provides direct sequencing of... Read more
Qualitative Test for the Detection of Nucleic Acid From SARS-CoV-2 IRVINE, Calif., (May 12, 2020) — Zymo Research announced today that the US Food and Drug Administration (FDA) has approved its Quick SARS-CoV-2 rRT-PCR Kit (R3011) for Emergency Use Authorization (EUA) for the detection of SARS-CoV-2, the virus that causes COVID-19. The kit is a qualitative test for the... Read more
Danaher Announces Offerings Of Common Stock And Mandatory Convertible Preferred Stock WASHINGTON, May 7, 2020 /PRNewswire/ — Danaher Corporation (NYSE:DHR) (“Danaher”) announced today that it has commenced concurrent offerings of $1.25 billion of shares of common stock and $1.25 billion of shares of Series B Mandatory Convertible Preferred Stock, subject to market and other conditions (the offerings).... Read more